NATCO Pharma Ltd. Share Price Today
Techno Funda Ratings
Key Metrics
Current Price
₹921.45Market Cap
₹ 16,504 Cr.Stock P/E
11.6ROE
16.9 %RSI
61.82Trend
BearishShare Price Chart
Technical Commentary
Buy or Sell Analysis
Company Overview
NATCO Pharma Limited (NATCO) is a vertically integrated, research and development focused pharmaceutical company engaged in developing, manufacturing, and marketing complex products for niche therapeutic areas. [1] NATCO has established its presence in all three business segments viz. finished dosage formulations (“FDF”), active pharmaceutical ingredients (“APIs”), Contract Manufacturing Business.[2]
Natco Pharma Ltd share price remains one of the actively tracked stocks on NSE among traders and long term investors.
The latest Natco Pharma Ltd share price NSE movement reflects ongoing investor interest driven by company fundamentals, sector performance and broader market sentiment.
From a technical analysis perspective, the Natco Pharma Ltd share price chart currently indicates a Bearish trend based on moving averages and RSI momentum analysis.
Technical Analysis
| Indicator | Value |
|---|---|
| Current Price | 921.45 |
| RSI (14) | 61.82 |
| 50 DMA | 964.89 |
| 200 DMA | 938.77 |
| Trend | Bearish |
| A/D Rating | D |
| RS Rating | 50 |
| EPS Rating | 50 |
| TI65 | 0.94 |
| TI65 Trend | Bearish |
Pivot Points Analysis
Daily pivot points for NATCO Pharma Ltd. calculated using previous trading session data. These levels help traders identify intraday support, resistance and breakout zones using Classic Pivot Point methodology.
Classic Pivot Points
| Level | Value |
|---|---|
| R3 | ₹943.66 |
| R2 | ₹935.28 |
| R1 | ₹928.36 |
| PP | ₹919.98 |
| S1 | ₹913.06 |
| S2 | ₹904.68 |
| S3 | ₹897.76 |
Financial Ratios
| Metric | Value |
|---|---|
| Market Cap | ₹ 16,504 Cr. |
| Current Price | ₹ 921 |
| High / Low | ₹ 1,227 / 789 |
| Stock P/E | 11.6 |
| Book Value | ₹ 515 |
| Dividend Yield | 0.65 % |
| ROCE | 17.1 % |
| ROE | 16.9 % |
| Face Value | ₹ 2.00 |
Quarterly Results
| Quarter | Sales | Profit | OPM |
|---|---|---|---|
| Mar 2023 | 898 | 276 | 38% |
| Jun 2023 | 1,140 | 420 | 46% |
| Sep 2023 | 1,031 | 369 | 44% |
| Dec 2023 | 759 | 213 | 35% |
| Mar 2024 | 1,068 | 386 | 47% |
| Jun 2024 | 1,363 | 668 | 59% |
| Sep 2024 | 1,371 | 676 | 59% |
| Dec 2024 | 475 | 132 | 8% |
| Mar 2025 | 1,221 | 406 | 45% |
| Jun 2025 | 1,329 | 480 | 43% |
| Sep 2025 | 1,363 | 518 | 42% |
| Dec 2025 | 647 | 151 | 25% |
| Mar 2026 | 739 | 269 | 17% |
Shareholding Pattern
| Holder | Holding |
|---|---|
| Promoters | 48.82% |
| FIIs | 11.73% |
| DIIs | 14.93% |
| Public | 24.53% |
| No. of Shareholders | 1,35,397 |
Pros and Cons
Pros
- Healthy return on equity of 16.9% indicating strong capital allocation efficiency.
Cons
- Primary trend direction remains weak, stuck underneath major defensive supply barriers.
Related NSE Stocks
Mahanagar Gas Ltd.
View Share Price Analysis →Coal India Ltd.
View Share Price Analysis →Punjab National Bank
View Share Price Analysis →Yes Bank Ltd.
View Share Price Analysis →Indian Renewable Energy Development Agency Ltd.
View Share Price Analysis →Indian Railway Catering And Tourism Corporation Ltd.
View Share Price Analysis →Emcure Pharmaceuticals Ltd.
View Share Price Analysis →CreditAccess Grameen Ltd.
View Share Price Analysis →Jain Resource Recycling Ltd.
View Share Price Analysis →Sundaram Finance Ltd.
View Share Price Analysis →Aurobindo Pharma Ltd.
View Share Price Analysis →Transformers And Rectifiers (India) Ltd.
View Share Price Analysis →Frequently Asked Questions
What is the current technical trend and RSI for Natco Pharma Ltd share?
Based on the latest closing data, the technical momentum for Natco Pharma Ltd is currently evaluated as Bearish. The stock is exhibiting an RSI (14) of 61.82, indicating it is trading in a neutral balanced zone. Key tracking supports are currently located near the daily pivots, with price relative to the 50 DMA (964.89) defining immediate multi-day trend patterns.
What are the key resistance and support pivot points for Natco Pharma Ltd?
According to Classic Pivot Point methodologies, the core trading floor for Natco Pharma Ltd today centers at a Pivot Point (PP) of ₹919.98. Upside resistance challenges are calculated at R1: ₹928.36, R2: ₹935.28, and R3: ₹943.66. Conversely, if selling pressure intensifies, immediate floor support targets are positioned at S1: ₹913.06, S2: ₹904.68, and S3: ₹897.76.
How does the fundamental ROE and P/E ratio look for Natco Pharma Ltd?
Natco Pharma Ltd is currently trading with a valuation metrics context of a Stock P/E of 11.6, against a core structural efficiency Return on Equity (ROE) standing at 16.9 %. This fundamental operational efficiency baseline is coupled with an EPS Rating of 50, allowing investors to track how corporate profitability trends align with current price discovery cycles on the National Stock Exchange (NSE).
Should I buy or sell Natco Pharma Ltd shares based on corporate rankings?
Our dynamic trade matrix suggests a status of: Chronic Downtrend / Potential Value Trap (Neutral / Avoid). Natco Pharma Ltd con... For long-term portfolios, decision-making should match the stock's market performance profile, which currently displays an institutional Accumulation/Distribution (A/D) grade of D, a Relative Strength (RS) ranking of 50, and long-term trend backing from the TI65 indicator (Bearish pattern).